FDA TPSAC - Report on Menthol Cigarettes..

March 22, 2011


TPSAC - Report on Menthol Cigarettes, presented to the FDA's Center for Tobacco Products..


Now the committee's report has been completed how many times are we going to hear... there is no required deadline or timeline for FDA to act on the issue of menthol in cigarettes. However, Lawrence R. Deyton, director of the Center for Tobacco Products said, "We recognize the strong interest in this issue among all stakeholders and will continue to communicate the steps the FDA is taking as it determines what future regulatory actions, if any, are warranted." He added that FDA intends to provide its first progress report on the review of the TPSAC recommendations in approximately 90 days.

Menthol Cigarettes - alter the menthol concentration so cigarettes will not be so appealing to young smokers..

U.S. FDA for our children must limit the availability of menthol cigarettes..

Chapter 1: OVERVIEW: WHAT THIS REPORT IS ABOUT

Chapter 2: TPSAC’S APPROACH TO ITS CHARGE

CHAPTER 3: THE PHYSIOLOGICAL EFFECTS OF MENTHOL CIGARETTES

CHAPTER 4: PATTERNS OF MENTHOL CIGARETTE SMOKING

CHAPTER 5: MARKETING AND CONSUMER PERCEPTION

CHAPTER 6: EFFECTS OF MENTHOL CIGARETTES ON INITIATION, ADDICTION AND CESSATION

CHAPTER 7: EFFECTS OF MENTHOL ON THE DISEASE RISKS OF SMOKING

CHAPTER 8: CONCLUSIONS AND RECOMMENDATIONS . . .

OVERALL CONCLUSIONS

Based on the conclusions to the nine questions, TPSAC provides the following general conclusions:

• Menthol cigarettes have an adverse impact on public health in the United States.

• There are no public health benefits of menthol compared to non•menthol cigarettes.